Skip to content

Cash ratio at other companies

AbbVie logo
AbbVieABBV
0.2×+0.1×
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
0.0×
Lifevantage Corporation logo
Lifevantage CorporationLFVN
0.6×-0.1×
Estee Lauder Companies Inc. logo
Estee Lauder Companies Inc.EL
0.5×0.0×
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
0.6×+0.4×
NuSkin Enterprises logo
NuSkin EnterprisesNUS
0.8×0.0×

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$204.4M-45.2%
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.75M-61.5%
Enterprise value$11.24M-96.2%
P/S0.3×-0.4×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Calculated from The Beauty Health Company’s reported figures.

Based on the most recent quarter.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's cash ratio?
The Beauty Health Company (SKIN) reported cash ratio of 1.3× in Q1 2026.
How has The Beauty Health Company's cash ratio changed year-over-year?
The Beauty Health Company's cash ratio decreased by 77.8% year-over-year, from 5.9× to 1.3×.
What is the long-term trend for The Beauty Health Company's cash ratio?
Over 5 years (2020 to 2025), The Beauty Health Company's cash ratio has grown at a 32.4% compound annual growth rate (CAGR), from 0.3× to 1.2×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.